iShares Health Innovation Active ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
BlackRock Cash Funds: Institutional, SL Agency Shares | 395.94 k | 395.66 k shares | 9.73 | Short-term investment vehicle | Long | USA |
BlackRock Cash Funds: Treasury, SL Agency Shares | 280.00 k | 280.00 k shares | 6.88 | Short-term investment vehicle | Long | USA |
BSX Boston Scientific Corporation | 198.96 k | 2.37 k shares | 4.89 | Common equity | Long | USA |
ISRG Intuitive Surgical, Inc. | 173.82 k | 345.00 shares | 4.27 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 167.42 k | 628.00 shares | 4.11 | Common equity | Long | USA |
ARGX argenx SE | 147.16 k | 251.00 shares | 3.62 | Common equity | Long | Netherlands |
WST West Pharmaceutical Services, Inc. | 120.71 k | 392.00 shares | 2.97 | Common equity | Long | USA |
MTD Mettler-Toledo International Inc. | 103.34 k | 80.00 shares | 2.54 | Common equity | Long | USA |
Roche Holding AG
|
93.59 k | 302.00 shares | 2.30 | Common equity | Long | Switzerland |
WAT Waters Corporation | 93.38 k | 289.00 shares | 2.29 | Common equity | Long | USA |
DHR Danaher Corporation | 90.16 k | 367.00 shares | 2.22 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 88.06 k | 156.00 shares | 2.16 | Common equity | Long | USA |
TECH Bio-Techne Corporation | 82.53 k | 1.12 k shares | 2.03 | Common equity | Long | USA |
Sonova Holding AG
|
82.34 k | 225.00 shares | 2.02 | Common equity | Long | Switzerland |
SRPT Sarepta Therapeutics, Inc. | 72.07 k | 572.00 shares | 1.77 | Common equity | Long | USA |
RGEN Repligen Corporation | 70.89 k | 528.00 shares | 1.74 | Common equity | Long | USA |
SNY Sanofi | 66.05 k | 1.25 k shares | 1.62 | Common equity | Long | France |
RYTM Rhythm Pharmaceuticals, Inc. | 64.29 k | 1.35 k shares | 1.58 | Common equity | Long | USA |
MOH Molina Healthcare, Inc. | 60.07 k | 187.00 shares | 1.48 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 59.09 k | 158.00 shares | 1.45 | Common equity | Long | USA |
ALGN Align Technology, Inc. | 59.05 k | 288.00 shares | 1.45 | Common equity | Long | USA |
PODD Insulet Corporation | 50.94 k | 220.00 shares | 1.25 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 50.39 k | 419.00 shares | 1.24 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 49.38 k | 558.00 shares | 1.21 | Common equity | Long | USA |
Merus NV
|
48.43 k | 970.00 shares | 1.19 | Common equity | Long | Netherlands |
INSM Insmed Incorporated | 48.37 k | 719.00 shares | 1.19 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 47.28 k | 1.15 k shares | 1.16 | Common equity | Long | Canada |
BMRN BioMarin Pharmaceutical Inc. | 46.85 k | 711.00 shares | 1.15 | Common equity | Long | USA |
ONC BeiGene, Ltd. | 42.55 k | 210.00 shares | 1.05 | Common equity | Long | Cayman Islands |
EXAS Exact Sciences Corporation | 41.84 k | 607.00 shares | 1.03 | Common equity | Long | USA |
SYK Stryker Corporation | 40.26 k | 113.00 shares | 0.99 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 39.26 k | 442.00 shares | 0.96 | Common equity | Long | USA |
HOLX Hologic, Inc. | 38.33 k | 474.00 shares | 0.94 | Common equity | Long | USA |
EHC Encompass Health Corporation | 37.70 k | 379.00 shares | 0.93 | Common equity | Long | USA |
LH Laboratory Corporation of America Holdings | 37.66 k | 165.00 shares | 0.93 | Common equity | Long | USA |
Lonza Group AG
|
36.92 k | 60.00 shares | 0.91 | Common equity | Long | Switzerland |
BPMC Blueprint Medicines Corporation | 36.32 k | 415.00 shares | 0.89 | Common equity | Long | USA |
INSP Inspire Medical Systems, Inc. | 35.89 k | 184.00 shares | 0.88 | Common equity | Long | USA |
PEN Penumbra, Inc. | 34.33 k | 150.00 shares | 0.84 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 34.14 k | 321.00 shares | 0.84 | Common equity | Long | USA |
NTRA Natera, Inc. | 33.63 k | 278.00 shares | 0.83 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 33.49 k | 1.29 k shares | 0.82 | Common equity | Long | USA |
Sartorius AG | 30.05 k | 116.00 shares | 0.74 | Preferred equity | Long | Germany |
ABT Abbott Laboratories | 30.04 k | 265.00 shares | 0.74 | Common equity | Long | USA |
QIAGEN NV
|
28.92 k | 687.00 shares | 0.71 | Common equity | Long | Netherlands |
COO The Cooper Companies, Inc. | 27.53 k | 263.00 shares | 0.68 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 25.70 k | 774.00 shares | 0.63 | Common equity | Long | USA |
Roivant Sciences Ltd
|
25.47 k | 2.21 k shares | 0.63 | Common equity | Long | Bermuda |
STERIS PLC
|
25.29 k | 114.00 shares | 0.62 | Common equity | Long | Ireland |
NRIX Nurix Therapeutics, Inc. | 25.24 k | 1.03 k shares | 0.62 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 25.23 k | 53.00 shares | 0.62 | Common equity | Long | USA |
GEHC GE HealthCare Technologies Inc. | 24.89 k | 285.00 shares | 0.61 | Common equity | Long | USA |
BDX Becton, Dickinson and Company | 24.53 k | 105.00 shares | 0.60 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals, Inc. | 23.11 k | 387.00 shares | 0.57 | Common equity | Long | USA |
Zealand Pharma A/S
|
22.97 k | 199.00 shares | 0.56 | Common equity | Long | Denmark |
PTCT PTC Therapeutics, Inc. | 22.24 k | 557.00 shares | 0.55 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 20.83 k | 412.00 shares | 0.51 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 20.72 k | 672.00 shares | 0.51 | Common equity | Long | UK |
GH Guardant Health, Inc. | 20.24 k | 925.00 shares | 0.50 | Common equity | Long | USA |
ICON PLC
|
18.66 k | 84.00 shares | 0.46 | Common equity | Long | Ireland |
INCY Incyte Corporation | 18.53 k | 250.00 shares | 0.46 | Common equity | Long | USA |
Biohaven Ltd
|
18.26 k | 367.00 shares | 0.45 | Common equity | Long | Virgin Islands (British) |
ACLX Arcellx, Inc. | 17.53 k | 208.00 shares | 0.43 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals, Inc. | 17.22 k | 387.00 shares | 0.42 | Common equity | Long | USA |
EW Edwards Lifesciences Corporation | 17.02 k | 254.00 shares | 0.42 | Common equity | Long | USA |
BNTX BioNTech SE | 16.40 k | 145.00 shares | 0.40 | Common equity | Long | Germany |
PTGX Protagonist Therapeutics, Inc. | 16.36 k | 357.00 shares | 0.40 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 16.20 k | 422.00 shares | 0.40 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 16.14 k | 1.31 k shares | 0.40 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 15.56 k | 710.00 shares | 0.38 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 15.19 k | 284.00 shares | 0.37 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 14.98 k | 122.00 shares | 0.37 | Common equity | Long | Denmark |
ARVN Arvinas, Inc. | 14.72 k | 557.00 shares | 0.36 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 14.31 k | 496.00 shares | 0.35 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 14.28 k | 280.00 shares | 0.35 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 14.04 k | 255.00 shares | 0.35 | Common equity | Long | USA |
GKOS Glaukos Corporation | 14.02 k | 106.00 shares | 0.34 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 13.50 k | 811.00 shares | 0.33 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 12.96 k | 321.00 shares | 0.32 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 12.93 k | 306.00 shares | 0.32 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics | 12.30 k | 265.00 shares | 0.30 | Common equity | Long | Cayman Islands |
Helix Acquisition Corp II
|
11.83 k | 1.14 k shares | 0.29 | Common equity | Long | Cayman Islands |
KROS Keros Therapeutics, Inc. | 11.78 k | 203.00 shares | 0.29 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 11.51 k | 343.00 shares | 0.28 | Common equity | Long | USA |
DXCM DexCom, Inc. | 10.92 k | 155.00 shares | 0.27 | Common equity | Long | USA |
RDNT RadNet, Inc. | 10.73 k | 165.00 shares | 0.26 | Common equity | Long | USA |
NARI Inari Medical, Inc. | 10.41 k | 215.00 shares | 0.26 | Common equity | Long | USA |
Alkermes PLC
|
10.25 k | 399.00 shares | 0.25 | Common equity | Long | Ireland |
TCRX TScan Therapeutics, Inc. | 9.93 k | 2.19 k shares | 0.24 | Common equity | Long | USA |
Gerresheimer AG
|
9.69 k | 115.00 shares | 0.24 | Common equity | Long | Germany |
BBIO BridgeBio Pharma, Inc. | 9.04 k | 386.00 shares | 0.22 | Common equity | Long | USA |
Nyxoah SA
|
8.99 k | 946.00 shares | 0.22 | Common equity | Long | Belgium |
SRRK Scholar Rock Holding Corporation | 8.28 k | 291.00 shares | 0.20 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 7.75 k | 87.00 shares | 0.19 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 7.34 k | 163.00 shares | 0.18 | Common equity | Long | Cayman Islands |
Novocure Ltd
|
7.09 k | 467.00 shares | 0.17 | Common equity | Long | Jersey |
VKTX Viking Therapeutics, Inc. | 6.75 k | 93.00 shares | 0.17 | Common equity | Long | USA |
Immatics NV
|
6.02 k | 662.00 shares | 0.15 | Common equity | Long | Netherlands |
GPCR Structure Therapeutics Inc. | 5.84 k | 142.00 shares | 0.14 | Common equity | Long | Cayman Islands |
AUTL Autolus Therapeutics plc | 5.83 k | 1.73 k shares | 0.14 | Common equity | Long | UK |
ORIC ORIC Pharmaceuticals, Inc. | 5.54 k | 591.00 shares | 0.14 | Common equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 5.32 k | 779.00 shares | 0.13 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 5.28 k | 345.00 shares | 0.13 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 5.20 k | 116.00 shares | 0.13 | Common equity | Long | USA |
BDTX Black Diamond Therapeutics, Inc. | 5.03 k | 1.83 k shares | 0.12 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 4.78 k | 204.00 shares | 0.12 | Common equity | Long | UK |
AC Immune SA
|
4.74 k | 1.67 k shares | 0.12 | Common equity | Long | Switzerland |
ALLO Allogene Therapeutics, Inc. | 4.60 k | 1.80 k shares | 0.11 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 4.55 k | 128.00 shares | 0.11 | Common equity | Long | USA |
SGMT Sagimet Biosciences Inc. | 4.47 k | 867.00 shares | 0.11 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 4.01 k | 226.00 shares | 0.10 | Common equity | Long | USA |
CABA Cabaletta Bio, Inc. | 3.94 k | 1.11 k shares | 0.10 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 3.73 k | 194.00 shares | 0.09 | Common equity | Long | USA |
WaVe Life Sciences Ltd
|
3.56 k | 260.00 shares | 0.09 | Common equity | Long | Singapore |
SAGE Sage Therapeutics, Inc. | 3.28 k | 540.00 shares | 0.08 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 3.08 k | 113.00 shares | 0.08 | Common equity | Long | USA |
PRME Prime Medicine, Inc. | 2.91 k | 751.00 shares | 0.07 | Common equity | Long | USA |
BMEA Biomea Fusion, Inc. | 2.86 k | 305.00 shares | 0.07 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 2.34 k | 272.00 shares | 0.06 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 2.28 k | 70.00 shares | 0.06 | Common equity | Long | USA |
VIGL Vigil Neuroscience, Inc. | 2.09 k | 552.00 shares | 0.05 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 1.96 k | 230.00 shares | 0.05 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 1.88 k | 235.00 shares | 0.05 | Common equity | Long | USA |
Prothena Corp PLC
|
1.70 k | 100.00 shares | 0.04 | Common equity | Long | Ireland |
NMRA Neumora Therapeutics, Inc. Common Stock | 1.59 k | 139.00 shares | 0.04 | Common equity | Long | USA |
NUVB Nuvation Bio Inc. | 1.59 k | 718.00 shares | 0.04 | Common equity | Long | USA |
TNYA Tenaya Therapeutics, Inc. | 1.20 k | 623.00 shares | 0.03 | Common equity | Long | USA |
SEPN Septerna, Inc. Common Stock | 1.01 k | 44.00 shares | 0.02 | Common equity | Long | USA |
KYTX Kyverna Therapeutics, Inc. | 607.06 | 127.00 shares | 0.01 | Common equity | Long | USA |
LXEO Lexeo Therapeutics, Inc. Common Stock | 553.00 | 70.00 shares | 0.01 | Common equity | Long | USA |
CRVO CervoMed Inc. | 477.75 | 35.00 shares | 0.01 | Common equity | Long | USA |
CONTRA ABIOMED INC | 408.36 | 246.00 shares | 0.01 | Long | USA | |
CONTRA MIRATI THERAPEU | 250.50 | 334.00 shares | 0.01 | Long | USA | |
CONTRA FREQUENCY THERA | 0 | 420.00 shares | 0.00 | Long | USA |